Links to 6 New HCV Articles

[Guest guest]

Abbott Reports Positive 12-week Results From Phase 2 Study Of Hepatitis C Drug

RTT News

ABT-450/r is an investigational, oral protease inhibitor being developed for the

treatment of hepatitis C or HCV infection. Hepatitis C is a liver disease and

the virus is primarily spread through direct contact with the blood of an

infected person. ...

See all stories on this topic »

STI check – Hepatitis C

Sydney Star Observer

Hepatitis means inflammation of the liver. Hepatitis C virus (HCV) causes damage

to the liver and this can lead to cirrhosis, (scarring of the liver), and

eventually liver failure and death. The virus is spread by blood to blood

contact. ...

See all stories on this topic »

Cirrhosis and HCC Increasing Among Hepatitis C Patients

Becker's ASC Review

By Jaimie Oh | April 04, 2011 The incidence of cirrhosis and its related

complications, such as hepatic decompensation and hepatocellular carcinoma, in

hepatitis C-infected patients has increased dramatically over the past 10 years,

according to a ...

See all stories on this topic »

Acute Hepatitis A Virus Infection Without IgM Antibodies to Hepatitis A Virus

ls of Internal Medicine

Background: Hepatitis A virus (HAV) is the leading cause of acute viral

hepatitis in industrialized countries. Diagnosis of acute HAV infection is

usually based on detection of anti-HAV IgM antibodies, which are present in more

than 99% of affected ...

See all stories on this topic »

Potential hepatitis C drug's step forward

PhysOrg.com (press release)

Inhibitex, the US biopharmaceutical company working on potential anti-viral

drugs with Prof McGuigan's laboratory in the Welsh School of Pharmacy, has

just announced the successful conclusion of the initial phase 1 trials of

INX-189 in hepatitis ...

See all stories on this topic »

New Hope for Patients With Hepatitis C Infection

MedIndia

by Sheela Philomena on April 04, 2011 at 10:20 AM Scientists have identified a

new range of protease inhibitors that aid treat patients with chronic hepatitis

C infection. The treatments have been tested for efficacy and safety in

combination with ...

See all stories on this topic »

[Guest guest]

Abbott Reports Positive 12-week Results From Phase 2 Study Of Hepatitis C Drug

RTT News

ABT-450/r is an investigational, oral protease inhibitor being developed for the

treatment of hepatitis C or HCV infection. Hepatitis C is a liver disease and

the virus is primarily spread through direct contact with the blood of an

infected person. ...

See all stories on this topic »

STI check – Hepatitis C

Sydney Star Observer

Hepatitis means inflammation of the liver. Hepatitis C virus (HCV) causes damage

to the liver and this can lead to cirrhosis, (scarring of the liver), and

eventually liver failure and death. The virus is spread by blood to blood

contact. ...

See all stories on this topic »

Cirrhosis and HCC Increasing Among Hepatitis C Patients

Becker's ASC Review

By Jaimie Oh | April 04, 2011 The incidence of cirrhosis and its related

complications, such as hepatic decompensation and hepatocellular carcinoma, in

hepatitis C-infected patients has increased dramatically over the past 10 years,

according to a ...

See all stories on this topic »

Acute Hepatitis A Virus Infection Without IgM Antibodies to Hepatitis A Virus

ls of Internal Medicine

Background: Hepatitis A virus (HAV) is the leading cause of acute viral

hepatitis in industrialized countries. Diagnosis of acute HAV infection is

usually based on detection of anti-HAV IgM antibodies, which are present in more

than 99% of affected ...

See all stories on this topic »

Potential hepatitis C drug's step forward

PhysOrg.com (press release)

Inhibitex, the US biopharmaceutical company working on potential anti-viral

drugs with Prof McGuigan's laboratory in the Welsh School of Pharmacy, has

just announced the successful conclusion of the initial phase 1 trials of

INX-189 in hepatitis ...

See all stories on this topic »

New Hope for Patients With Hepatitis C Infection

MedIndia

by Sheela Philomena on April 04, 2011 at 10:20 AM Scientists have identified a

new range of protease inhibitors that aid treat patients with chronic hepatitis

C infection. The treatments have been tested for efficacy and safety in

combination with ...

See all stories on this topic »